XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 2,130 $ 554
Prepaid R&D services- related party (see Note 7 and Note 12) 1,814 380
Prepaid R&D services (see Note 7) 279
Prepaid expenses and other current assets 1,726 1,781
Total current assets 5,949 2,715
Operating lease right-of-use assets. net 234 263
Property, plant and equipment, net 41 40
Prepaid expenses and other long-term assets 1,097 1,175
Total assets 7,321 4,193
Current liabilities    
Accounts payable 714 1,428
Accrued expenses and other current liabilities 1,045 1,963
Operating lease liability, current portion 126 119
Convertible promissory note payable 800
Total current liabilities 4,548 10,741
Operating lease liability, non-current portion 78 107
Derivative warrant liability 8 138
Total liabilities 4,634 10,986
Commitments and contingencies (see Note 15)
Stockholders’ equity (deficit)    
Common stock, par value $0.0001; 250,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively, 9,512,058 shares and 1,384,801 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 19 14
Preferred stock, par value $0.0001; 1,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; nil shares issued and outstanding at March 31, 2025 and December 31, 2024
Additional paid-in capital 36,569 21,880
Accumulated deficit (34,247) (29,101)
Accumulated other comprehensive income 346 414
Total stockholders’ equity (deficit) 2,687 (6,793)
Total liabilities and stockholders’ equity (deficit) 7,321 4,193
Nonrelated Party [Member]    
Current liabilities    
Convertible promissory notes payable at fair value 2,663 2,985
Notes payable 150
Related Party [Member]    
Current liabilities    
Convertible promissory notes payable at fair value 2,871
Notes payable $ 425